Changes that help
Habits that help
- Do not use someone else’s pen or lend yours, even if you change the needle.
- Keep your medicines in their original packaging and follow the storage instructions in the patient information leaflet.
The question often comes up in a consultation after someone hears that a person close to them is using an injection pen. It is understandable to want to know whether that treatment might suit you, but someone else’s experience does not show that a medicine is appropriate for you.
Semaglutide is the active ingredient in Ozempic, and tirzepatide is the active ingredient in Mounjaro. Ozempic is authorised for type 2 diabetes [2]. Mounjaro is authorised for type 2 diabetes and, in adults who meet certain body mass index criteria, for weight management [3]. To understand the range of treatments, start with GLP-1 medicines.
Can you buy Ozempic or Mounjaro online without a prescription in Spain?
Ozempic and Mounjaro cannot legally be sold online in Spain. The AEMPS (Spanish Agency for Medicines and Medical Devices) reminds patients that GLP-1 analogues require a prescription and that prescription-only medicines cannot be sold online [1]. Spanish law only allows the online sale of medicines that do not require a prescription [4].
There are two steps in the legal process. First, a medical consultation assesses whether the treatment is indicated and issues a prescription when appropriate. Then an authorised pharmacy dispenses the medicine. An offer that bypasses the prescription removes both clinical and pharmacy safeguards [1] [4].
Having an electronic prescription does not make a website selling the medicine legal either. Even if the website asks to see it, online sales of a prescription-only medicine are still not permitted [4]. If you are unsure how to access treatment, speak to your doctor or pharmacist.
What could be behind an offer with no prescription?
Counterfeiting can affect the contents, the amount of active ingredient or the product’s origin. According to the AEMPS, these illegal products may not contain what they claim to, or may contain harmful substances in dangerous amounts. This could lead to an unexpected serious effect, an interaction with other medicines or a treatment that has no effect [1].
In 2023, counterfeit pens labelled as Ozempic were detected at wholesalers in the European Union and the United Kingdom [5]. There was no evidence that they reached anyone through a legal pharmacy. Outside that supply chain, however, nobody checks what you receive [1] [5].
There are two separate uncertainties. The product may not contain the active ingredient, leaving your health problem untreated. It may also contain a different substance and cause an effect you were not expecting [1]. Neither uncertainty can be resolved by looking at a photo or reading other buyers’ reviews.
If an offer lets you bypass the prescription, it also bypasses the assessment that determines whether the treatment is right for you.
What if the pen contains the genuine medicine?
Storage matters too. The summaries of product characteristics for Ozempic and Mounjaro specify cold-storage conditions, with exceptions depending on the presentation and whether the pen is already in use [2] [3]. Outside the authorised supply chain, you cannot check transport, storage or traceability.
Lack of follow-up adds another risk. Before and during treatment, someone needs to review your medical conditions, other medicines and any symptoms that arise [2] [3]. Nausea or vomiting may call for changes, and some symptoms need prompt attention. A pen that looks normal does not confirm what it contains or how it has been stored.
This is especially important if you take medicines for diabetes. The Ozempic product information warns of a higher risk of hypoglycaemia (low blood sugar) when it is used with insulin or medicines that can lower blood sugar too much. It asks for their doses to be reviewed when treatment starts [2]. This review should be carried out by the person treating your diabetes. A seller who does not know your medical history cannot do it.
A very low price may raise suspicions, but a high price guarantees nothing either. Do not rely on a photo, a testimonial or supposed official endorsement: fraudulent websites use logos from official bodies and fake recommendations [1].
“People I know are injecting it”: what we see in consultations
Sharing experiences can help you come up with questions, but it does not replace a medical assessment. Two people may have very different diagnoses, treatments and needs. And if you use someone else’s pen, you do not know how it was obtained or stored.

If someone obtained it outside the medical supply chain, the best thing is to tell their doctor openly. Hiding it, or feeling ashamed, makes it harder to get help if symptoms appear.
Another question we often hear is whether you can start while waiting for an appointment. The answer is to wait for the assessment. In the meantime, you can work on an eating and activity plan tailored to you, without assuming that you will take a medicine.
Sometimes people looking for a medicine without a prescription are already struggling with their relationship with food or their body. If you have or have had an eating disorder, speak to your doctor and a mental health professional first. We explain more in GLP-1 medicines and eating disorders.
What should I do if I already have a pen from a questionable source?
Do not use it if you suspect it may be counterfeit, and take it to your pharmacy [5]. Tell your doctor or pharmacist where it came from, whether you have used it and whether you have noticed any symptoms. Do not change another treatment or try to make up for a dose if you do not know what it was.
If you have already used it, your doctor will decide what follow-up you need based on what happened. Keep the packaging and details of the offer to show them. The AEMPS asks people to report suspicious websites, adverts and products to the health authorities [1]. If you notice any of the signs listed under “When to seek medical help”, do not wait.
A safe option while you sort out access
Make an appointment with your GP or an endocrinologist to review your medical history, your goal and the options available. If cost or access is the problem, our guide to GLP-1 prices and funding explains the issue without resorting to offers with no prescription.
At your appointment, ask what indication the medicine is being considered for, which effects to look out for and who will help if problems arise during follow-up. If an offer made you hesitate, mention it without feeling embarrassed. The assessment depends on having all the information.
To prepare your questions, you can read the information about Ozempic and Mounjaro, and our guide to semaglutide, the active ingredient in Ozempic. These resources do not replace a prescription.
With GLP-1 nutrition support, we work on eating habits, digestive symptoms and strength alongside your medical team. We can start with your habits even if access to the medicine has not yet been resolved. We do not prescribe medicines or change doses.
An offer with no prescription solves the access problem but leaves the important questions unanswered: whether the medicine is right for you, what it contains and who will monitor you. Those three questions belong in a medical consultation, with a prescription if appropriate.
If you already have a prescribed treatment, the GLP-1 nutrition support programme can help you maintain an eating and strength-training plan while your doctor supervises your medicine.
Your first step this week
Prepare for your appointment
Write down the medicines you take, your goal and the offer that made you hesitate, and take the note to your GP.

Your first 16 weeks on a GLP-1
- What to eat at each dose increase
- 7-day menu with five small meals
- How to protect your muscle and what to do about side effects
Where should we send it?
Free PDF, in your inbox in a moment.
Data controller: Alimmenta Tu Vida, S.L. Purpose: to send you the guide and, only if you tick the second box, tips by email on the topic. You can withdraw your consent and exercise your rights at [email protected]. Legal basis, recipients and retention periods are in our privacy policy.
When to see a doctor
When to seek medical help
When you are taking a GLP-1 medicine, we support your nutrition during and after treatment: eating enough protein, preserving muscle and doing strength training. When you stop, we help you maintain your weight through habits.
We do not prescribe medicines, adjust doses or replace the person who prescribed yours. If the medicine is causing problems, speak to your doctor.
Warning signs.
- Severe, persistent pain in the upper abdomen that spreads to your back, with vomiting [2]
- If you are vomiting or have diarrhoea and cannot drink or keep fluids down, contact a healthcare professional today [2].
- Pain in the upper right side of your abdomen, yellow skin or eyes, or very pale stools [2]
- If you have diabetes and take insulin or medicines that can lower your blood sugar too much, seek advice if your blood sugar drops [6].
- Your vision has changed and you have diabetic retinopathy [2]
What to do. If you have pain that spreads to your back with vomiting, go to A&E today or call 112: this could be pancreatitis (inflammation of the pancreas). If you have pain in the upper right side of your abdomen, yellow skin or eyes, or very pale stools, also go to A&E today. If you cannot keep fluids down, contact your doctor today; if you also feel dizzy when standing up or are barely passing urine, go to A&E. If you have severe low blood sugar (confusion, inability to swallow or needing help from another person), call 112. If your blood glucose is below 70 mg/dl and you can swallow, take 15-20 g of glucose and check it again after 15 minutes [6]. If you have mild low blood sugar or your vision has changed, contact the person who prescribed your medicine today or tomorrow. If you suddenly lose your sight, go to A&E.
In summary. Most troublesome effects of GLP-1 medicines are digestive, temporary and manageable. These are the few warning signs that mean you should stop and seek advice.
Alimmenta's GLP-1 programme
Make sure what you lose is fat, and that it lasts when you stop
We support you from the first dose until a year after you stop: protein, digestive symptoms, strength, body composition and an exit plan.
- Assessmentbefore you start
- Dose escalationweeks 0-16
- Active weight lossmonths 4-12
- Plateau and maintenancefrom month 12
- Landingup to a year after stopping
4.9 ★ Google5.0 Doctoralia2,047 reviews23,000+ patients
First visit · 45 min, in clinic or online
First visit €65
Recommended for a long treatment
10-visit pack · €550
€55 per visit. How long each phase lasts depends on you.
We don't prescribe or change your dose: your doctor does that. We work alongside them.
Keep reading

Ozempic, Mounjaro and Wegovy prices: how much they cost and what is funded
You have been offered a GLP-1 medicine and need to know how much you will pay each month…

“Natural Ozempic”: why no food or supplement does the same
You have seen videos calling a smoothie or herbal tea “natural Ozempic”, and you are wondering whether you…

Ozempic (semaglutide): what it is for, side effects and what to eat
If you have been prescribed Ozempic, you may be worried about nausea, a reduced appetite or what will…

GLP-1 medicines: what they are and which are available in Spain
Perhaps one of these medicines has been suggested to you and you would like to understand why there…
ConsultationNutrition support with GLP-1 (Ozempic, Wegovy) in Barcelona and online
The medicine takes away your appetite. What you eat even when you have less appetite, and what happens…
Book a visit →
Recipes for this goal
Sources
- Spanish Agency for Medicines and Medical Devices (AEMPS). The EMA and HMA warn of an increase in illegal medicines marketed as GLP-1 analogues. AEMPS Information Note 26/2025. 2025. https://www.aemps.gob.es/informa/la-ema-y-hma-advierten-del-aumento-de-medicamentos-ilegales-comercializados-como-analogos-de-glp1/
- Spanish Agency for Medicines and Medical Devices (AEMPS). Summary of product characteristics for Ozempic 0.25 mg solution for injection in a pre-filled pen. CIMA. Accessed 26/09/2026. https://cima.aemps.es/cima/dochtml/ft/117251002/
- Spanish Agency for Medicines and Medical Devices (AEMPS). Summary of product characteristics for Mounjaro 2.5 mg solution for injection in a pre-filled pen. CIMA. Accessed 26/09/2026. https://cima.aemps.es/cima/dochtml/ft/1221685002/FT_1221685002.html
- Spanish Agency for Medicines and Medical Devices (AEMPS). Information on the sale of medicines through websites and mobile applications. AEMPS. 2019. https://www.aemps.gob.es/informa/medIlegales/informacion-sobre-la-venta-de-medicamentos-a-traves-de-sitios-web-y-aplicaciones-para-moviles/
- European Medicines Agency (EMA). EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens. EMA. 2023. https://www.ema.europa.eu/en/news/ema-alerts-eu-patients-healthcare-professionals-reports-falsified-ozempic-pens
- American Diabetes Association Professional Practice Committee. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026. Diabetes Care. 2026. doi:10.2337/dc26-S006
Written and reviewed by

How we can help
Now, applied to you
Nutrition support with GLP-1 (Ozempic, Wegovy) in Barcelona and onlineThe medicine takes away your appetite. What you eat even when you have less appetite, and what happens when you stop it, is what we work on here.
4.9 on Google · 5.0 on Doctoralia · 2,047 reviews









